Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Mark on +44 1494 818 049 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
+44 1494 818 049

I just wanted to say a huge thank you to Zenopa for all of the help and advice you gave me in the build up to my 2 interviews and ultimate success in gaining employment.
Julie, 2013

Eisai licenses ChemAxon software for drug discovery

4 January 2012 00:00 in Pharmaceutical Company Product News

Eisai has bolstered its drug development pipeline through a new licensing deal for the use of ChemAxon software for clinical data management.

Patcore, the Japan-based agency for ChemAxon, has licensed the JChem Cartridge for Oracle software to the pharmaceutical company, allowing it to take advantage of new database storage and search technology.

The system is designed for the management of chemical structure information generated in discovery processes and aims to deliver faster performance, improved accuracy and greater flexibility than alternative solutions.

At the same time, Eisai will also be rolling out Patcore's structure compound control checking system CRAIS Checker - which it currently uses in its Japanese laboratories - on a global scale.

This software has been adopted by the majority of Japanese pharmaceutical companies and allows users to correctly identify controlled substances more efficiently and confidently.

Last month, Eisai augmented its research capabilities further by commencing operations at its new H3 Biomedicine research facility in Massachusetts.ADNFCR-8000103-ID-801254533-ADNFCR

Other news stories from 04/01/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2014 Zenopa Ltd